GALEN WETTERLING: Open Payments
NPI 1104385228 · AMHERST, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$293 in 9 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $154 · 2025 $293
Food & beverage: $294
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $138 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $31 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| TOLMAR, INC. | 1 | $22 |
| Azurity Pharmaceuticals, Inc. | 1 | $20 |
| Echosens North America, Inc. | 1 | $17 |
| Exact Sciences Corporation | 1 | $15 |
Products named: KISUNLA, CAPLYTA, SPRAVATO, SHINGRIX, MOUNJARO, FENSOLVI, HORIZANT, Fibroscan.
Industry payments across MA — which companies pay providers there.
